Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed two doses in advanced breast cancer
NCT00065533Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2003
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of pemetrexed in breast cancer, sponsored by Eli Lilly and Company. Started May 2003; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00065533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065533.